+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Recombinant Protein Market Report by Product, Application, End User, and Region 2024-2032

  • PDF Icon

    Report

  • 137 Pages
  • April 2024
  • Region: Global
  • IMARC Group
  • ID: 5742894
The global recombinant protein market size reached US$ 1.90 Billion in 2023. Looking forward, the market is projected to reach US$ 4.58 Billion by 2032, exhibiting a growth rate (CAGR) of 10.27% during 2023-2032.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth.

Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures.

Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product, application and end user.

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

1. What was the size of the global recombinant protein market in 2023?
2. What is the expected growth rate of the global recombinant protein market during 2024-2032?
3. What are the key factors driving the global recombinant protein market?
4. What has been the impact of COVID-19 on the global recombinant protein market?
5. What is the breakup of the global recombinant protein market based on application?
6. What is the breakup of the global recombinant protein market based on the end user?
7. What are the key regions in the global recombinant protein market?
8. Who are the key players/companies in the global recombinant protein market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Recombinant Protein Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hormones
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Growth Factors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytokines
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Drug Discovery and Development
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Academic Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biotechnology Research
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Biopharmaceutical Production
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical and Biopharmaceutical Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Contract Research Organization
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abcam plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bio-Techne Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bps Bioscience Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Enzo Biochem Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Genscript Biotech Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Novo Nordisk A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 ProSpec-Tany TechnoGene Ltd
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sanofi S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2023
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2023
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2023
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2023
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players

Companies Mentioned

  • Abcam plc
  • Amgen Inc.
  • Bio-RAD Laboratories Inc.
  • Bio-Techne Corporation
  • Bps Bioscience Inc.
  • Enzo Biochem Inc.
  • Genscript Biotech Corporation
  • Merck KGaA
  • Novo Nordisk A/S
  • ProSpec-Tany TechnoGene Ltd
  • Sanofi S.A.
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...

Table Information